The paper presents proposals which have been developed working with a range of stakeholders, on the the establishment of the four Regional Medicines Optimisation Committees (RMOCS) across England. The purpose of this paper is to test the proposals through a number of open questions.
A report of the discussions that took place at a workshop held in April 2016 to understand the key issues that will underpin the establishment of Regional Medicines Optimisation Committees (RMOC).
A summary of the content of 14 roadshows that took place in 2015. Each roadshow explained the mechanisms and context of the ‘Pharmaceutical Price Regulation Scheme’ (PPRS) and medicines optimisation in order to guide the formulation of strategic medicines optimisation action plans that could be implemented in each region across England.
NHS England has today launched an updated Medicines Optimisation Dashboard to help CCGs improve and understand how well patients across the country are being supported to use their medicines. The dashboard brings together data and aligns it to various themes including patient safety, mental health, cardiovascular disease, respiratory disease, diabetes, antibiotic prescribing and community pharmacy. […]
NHS England today (12 June) launches the Medicines Optimisation Prototype Dashboard, designed to encourage CCGs and trusts to think more about how well their patients are supported to use medicine and less about focusing on cost and volume of drugs. The prototype dashboard brings together in one place data from across sectors in areas such […]
NHS England has today started recruitment to the latest addition to its specialised commissioning Clinical Reference Group (CRG) structure. The Specialised Commissioning Medicines Optimisation CRG will work across all 74 service-specific CRGs. One of its key roles, working with experts from around the country, will be to ensure that the systems and levers currently in […]
NHS England is supporting the Royal Pharmaceutical Society’s call for health professionals and patients to work together to ensure better use of medicines. A guide, called Medicines Optimisation: helping patients make the most of medicines, has been published by the Society which provides frontline professionals with four guiding principles to make sure that the right […]
This guidance sets out 16 national medicines optimisation opportunities and signposts to resources to support integrated care boards (ICBs) to choose at least five to deliver alongside their local medicines optimisation priorities. The list of 16 is not provided in any priority order and reflects the breadth of opportunities that can be selected by ICBs […]
NHS England’s Medicines Value and Access function (MVA) provides the commercial capabilities to enable the NHS in England to secure innovative treatments and the everyday medicines that people rely on, in a way that achieves value for taxpayers. What are our missions? To secure patient access to clinically effective treatments in a way that delivers […]